Physician profile
Kevin Collon
NPI 1588167415
$17,601.05
in general payments reported to CMS, 2019-2025
6 companies · $11K in 2025
The $11K reported for 2025 was more than what 87% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $14.57 · 2024: $6,714 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $13K · Travel and Lodging: $3,189 · Food and Beverage: $1,912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $12,500.00 |
| Travel and Lodging | $3,188.82 |
| Food and Beverage | $1,912.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14,297.40 | 2024-2025 | Healicoil, Q-Fix |
| Stryker Corporation | $1,617.75 | 2024-2025 | Blueprint Patient Specific Instrumentation, Inspace, Alphavent |
| Arthrex, INC. | $1,503.11 | 2025 | |
| Piedmont Plus Innovation | $95.17 | 2025 | |
| Saxum Surgical, INC. | $73.05 | 2025 | |
| Biogen, INC. | $14.57 | 2023 | Tysabri, Vumerity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Collon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.